[1]
L. Ljubičić, “Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis”, Radiol Oncol, vol. 57, no. 3, pp. 397–404, Sep. 2023.